Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph’s Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat severe asthma.
In a study of over 200 participants with severe asthma, the new treatment was shown to have improved asthma symptoms and lung function, while reducing the need for corticosteroids by up to 70%.
According to Statistics Canada, eight per cent of Canadians aged 12 or older – approximately 2.4 million people – have been diagnosed with asthma. Of that, approximately 25% are considered to be severe cases of asthma.
Current treatments for severe asthma often include high doses of corticosteroids, such as prednisone, to control exacerbations. Reducing the need for corticosteroids with alternative treatments is preferable, since these medications are associated with serious side effects from prolonged use – including multi-organ toxicities and immunosuppression.
Parameswaran Nair, professor of medicine at McMaster and staff respirologist at St. Joseph’s Healthcare Hamilton, along with a team of researchers found that an antibody called dupilumab is effective in treating severe asthma in place of high doses of prednisone.
The results were published in the New England Journal of Medicine, one of the world’s most influential medical publications.
Researchers sought participants who had been using oral corticosteroids (prednisone) to treat severe asthma for at least six months prior to the study. In addition to their standard regimen of corticosteroids, patients received either dupilumab or a placebo during the 24 week trial. The corticosteroid dose was gradually reduced during weeks four to 20, and maintained at a low level for the final four weeks.
“The ability of dupilumab to increase lung function as markedly as it did in this study, even in the face of [corticosteroid] withdrawal, indicates that it appears to be inhibiting key drivers of lung inflammation,” the researchers noted.
Dupilumab works to treat asthma by blocking two specific proteins (called interleukin-4 and interleukin-13) that are associated with inflammation of the airways.
This technique was based on Nair’s previous research, (published in the New England Journal of Medicine in 2009 and in 2017). Those studies found that blocking another protein, interleukin-5, allowed patients with high eosinophil levels in their blood and airways to reduce their corticosteroid dose. Eosinophils are a type of white blood cell involved with the production of interleukins. High eosinophil levels are directly linked to an increased risk of severe asthma.
Unlike the previous studies, dupilumab was shown to be effective regardless of patients’ eosinophil levels. Despite the reduced prednisone dose, patients in this study not only experienced a decrease in asthma exacerbations, but their lung function also improved significantly.
“Ultimately, our goal is to find new treatment pathways that allow us to circumvent the use of corticosteroids,” said Nair.
“Since dupilumab showed a significant improvement on asthma control regardless of eosinophil levels, we may be able to use this treatment for a wider range of patients than we previously thought possible. This might be due to the broad effects on inflammation in asthma of the two proteins that we were able to block with dupilumab. The treatment was not associated with any serious side effects.”
The Latest on: Asthma
via Google News
The Latest on: Asthma
Camp for kids with diabetes, asthma opens in Myrtle Beach
on June 19, 2018 at 4:02 pm
This material may not be published, broadcast, rewritten, or redistributed. MYRTLE BEACH, SC (WBTW) - A camp for kids with diabetes and asthma started on Monday in Myrtle Beach. Camp Seven Seas and Camp Air Waves is sponsored by Grand Strand Health and ... […]
Small babies and asthma in later life
on June 19, 2018 at 5:14 am
Airway size in rats with a low birth weight is more varied than those born at a normal weight—which Western Australian scientists think may play a role in the development of asthma. Around 2.5 million Australians suffer from asthma, causing breathing ... […]
New asthma tool determines best treatment for severe asthma patients
on June 19, 2018 at 12:06 am
To help enable stronger communication and understanding between the clinician and patient, the CHEST Foundation, the charitable foundation of the American College of Chest Physicians, Allergy & Asthma Network and American College of Allergy, Asthma ... […]
Asthma on rise following Maria
on June 18, 2018 at 10:00 pm
SAN JUAN, Puerto Rico – Shortly after he turned 2, Yadriel Hernandez started struggling to breathe. His doctor prescribed an inhaler and an allergy pill for asthma, and his symptoms were mostly under control. Then Hurricane Maria devastated Puerto Rico ... […]
CHEST® Partners with Medscape to Launch the Moderate to Severe Asthma Center of Excellence
on June 18, 2018 at 1:03 pm
NEW YORK, June 18, 2018 /PRNewswire/ -- With prevalence on the increase since the early 1980s, asthma rates continue to rise, particularly in people age 65 and over. More than 25 million people in the U.S. have asthma, and it is the leading chronic disease ... […]
New tool determines best treatment plan for adults with severe asthma
on June 18, 2018 at 12:00 pm
One in 12 adults and one in 11 children in the United States are living with asthma, according to the Centers for Disease Control and Prevention (CDC). The communication between patients and clinicians is an important factor in proper management of a ... […]
If You Think Your Child Has Asthma, Listen Carefully For This 1 Thing in Their Breathing
on June 18, 2018 at 10:31 am
Chat with us on Facebook Messenger. Learn what's trending across POPSUGAR. Asthma is an upper respiratory illness of the lungs that can cause difficulty breathing. Having lived through numerous ER visits in the middle of the night with my two boys when ... […]
Puerto Rico faces a spike in asthma cases following Hurricane Maria
on June 18, 2018 at 8:57 am
Yahir Garcia receives one of his two daily treatments for asthma at a medical center in San Juan, Puerto Rico on May 29, 2018. (AP Photo/Ramon Espinosa)Ramon Espinosa / AP SAN JUAN, Puerto Rico — Shortly after he turned 2, Yadriel Hernandez started ... […]
Puerto Rico struggles with jump in asthma cases post-Maria
on June 18, 2018 at 8:19 am
Shortly after he turned 2, Yadriel Hernandez started struggling to breathe. His doctor prescribed an inhaler and an allergy pill for asthma, and his symptoms were mostly under control. Then Hurricane Maria devastated Puerto Rico, strewing mold-producing ... […]
via Bing News